Expanding criteria for living kidney donors: what are the limits?

Transplantation Reviews

Volumn 22, Issue 3, 2008, Pages 187-191

  Textor, Stephen ^a   Taler, Sandra ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE MONITORING; BODY WEIGHT; CARDIOVASCULAR RISK; DIABETES MELLITUS; DONOR SELECTION; FOLLOW UP; GLOMERULUS FILTRATION RATE; GRAFT SURVIVAL; HEALTH BEHAVIOR; HIGH RISK POPULATION; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INFORMED CONSENT; KIDNEY DONOR; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIVING DONOR; METABOLIC SYNDROME X; NEPHRECTOMY; NEPHROSCLEROSIS; OBESITY; PROTEINURIA; RISK ASSESSMENT; SMOKING; WEIGHT GAIN;

EID: 45049084677     PISSN: 0955470X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trre.2008.04.005     Document Type: Article

References (25)

1. Adams P.L., Cohen D.J., Danovitch G.M., et al. The nondirected live-kidney donor: ethical considerations and practice guidelines: A National Conference Report. Transplantation 74 (2002) 582-589
2. Vastag B. Living-donor transplants reexamined: experts cite growing concerns about safety of donors. JAMA 290 (2003) 181-182
3. Mandelbrot D.A., Pavlakis M., Danovitch G.M., et al. The medical evaluation of living kidney donors: a survey of US transplant centers. Am J Transplant 7 (2007) 2333-2343
4. Velosa J.A., Offord K.P., and Schroeder D.R. Effect of age, sex, and glomerular filtration rate on renal function outcome of living kidney donors. Transplantation 60 (1995) 1618-1621
5. Pena de la Vega L.S., Torres A., Bohorquez H.E., et al. Patient and graft outcomes from older living kidney donors are similar to those from younger donors despite lower GFR. Kidney Int 66 (2004) 1654-1661
6. Baskin-Bey E.S., Kremers W., and Nyberg S.L. Improving utilization of deceased donor kidneys by matching recipient and graft survival. Transplantation 82 (2006) 10-14
7. Fields L.E., Burt V.L., Cutler J.A., et al. The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension 44 (2004) 398-404
8. Klag M.J., Whelton P.K., Randall B.L., et al. Blood pressure and end-stage renal disease in men. N Engl J Med 334 (1996) 13-18
9. Brancati F.L., Whelton P.K., Randall B.L., et al. Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial. JAMA 278 (1997) 2069-2074
10. Hsu C.Y. Does treatment of non-malignant hypertension reduce the incidence of renal dysfunction? A meta-analysis of 10 randomised, controlled trials. J Hum Hypertens 15 (2001) 99-106
11. Beevers D.G., and Lip G.Y.H. Does non-malignant essential hypertension cause renal damage? A clinician's view. J Hum Hypertens 10 (1996) 695-699
12. Hsu C.Y., McCulloch C.E., Darbinian J., et al. Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. Arch Intern Med 165 (2005) 923-928
13. Torres V.E., Offord K.P., Anderson C.F., et al. Blood pressure determinants in living-related renal allograft donors and their recipients. Kidney Int 31 (1987) 1383-1390
14. Chobanian A.V., Bakris G.L., Black H.R., et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42 (2003) 1206-1252
15. Textor S.C., Taler S.J., Larson T.S., et al. Blood pressure evaluation among older living donors. J Am Soc Nephrol 14 (2003) 2159-2167
16. Williams B. Recent Hypertension Trials: implications and controversies. J Am Coll Cardiol 45 (2005) 813-827
17. Ellison M.D., McBride M.A., Taranto S.E., et al. Living kidney donors in need of kidney transplants: a report from the organ procurement and transplantation network. Transplantation 74 (2002) 1349-1351
18. Flegal K.M., Carroll M.D., Ogden C.L., et al. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 288 (2002) 1723-1727
19. Kip K.E., Marroquin O.C., Kelley D.E., et al. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE). Circulation 109 (2004) 706-713
20. Davis C.L., and Delmonico F.L. Living-donor kidney transplantation: a review of the current practices for the live donor. J Am Soc Nephrol 16 (2005) 2098-2110
21. Adelman R.D. Obesity and renal disease. Curr Opin Nephrol Hypertens 11 (2002) 331-335
22. Praga M., Hernández E., Herrero J.C., et al. Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy. Kidney Int 58 (2000) 2111-2118
23. Heimbach J.K., Taler S.J., Prieto M., et al. Obesity in living kidney donors: clinical characteristics and outcomes in the era of laparoscopic donor nephrectomy. Am J Transplant 5 (2005) 1057-1064
24. Hsu C.Y., McCulloch C.E., Iribarren C., et al. Body mass index and risk for end-stage renal disease. Ann Intern Med 144 (2006) 21-28
25. Rea D.J., Heimbach J.K., Grande J.P., et al. Glomerular volume and renal histology in obese and non-obese living kidney donors. Kidney Int 70 (2006) 1636-1641